Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

[Research progress of effect of anti-diabetic traditional Chinese medicines based on regulation of glucose metabolic enzyme].

Ji L, Tang XQ, Peng JY.

Zhongguo Zhong Yao Za Zhi. 2012 Dec;37(23):3519-25. Review. Chinese.

PMID:
23477131
2.

Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus.

Li WL, Zheng HC, Bukuru J, De Kimpe N.

J Ethnopharmacol. 2004 May;92(1):1-21. Review.

PMID:
15099842
3.

Evaluation of antidiabetic potential of selected traditional Chinese medicines in STZ-induced diabetic mice.

He K, Li X, Chen X, Ye X, Huang J, Jin Y, Li P, Deng Y, Jin Q, Shi Q, Shu H.

J Ethnopharmacol. 2011 Oct 11;137(3):1135-42. doi: 10.1016/j.jep.2011.07.033. Epub 2011 Jul 20.

PMID:
21798327
4.

[A new target for diabetes therapy: advances in the research of glycogen synthase kinase-3 inhibitors].

Liu SN, Shen ZF.

Yao Xue Xue Bao. 2007 Dec;42(12):1227-31. Review. Chinese.

PMID:
18338632
5.

Metabonomic analysis of the therapeutic effect of Zhibai Dihuang Pill in treatment of streptozotocin-induced diabetic nephropathy.

Zhao L, Gao H, Zhao Y, Lin D.

J Ethnopharmacol. 2012 Aug 1;142(3):647-56. doi: 10.1016/j.jep.2012.05.031. Epub 2012 Jun 9.

PMID:
22687255
6.

Berberine acutely inhibits the digestion of maltose in the intestine.

Li ZQ, Zuo DY, Qie XD, Qi H, Zhao MQ, Wu YL.

J Ethnopharmacol. 2012 Jul 13;142(2):474-80. doi: 10.1016/j.jep.2012.05.022. Epub 2012 May 22.

PMID:
22626925
7.

Research progress on anti-diabetic Chinese medicines.

Li YJ, Xu HX.

Zhong Yao Cai. 2006 Jun;29(6):621-4. Review.

PMID:
17039886
8.

[New classes of drugs in the pipeline. New in the treatment of diabetes mellitus].

Steri R, Schubert-Zsilavecz M.

Pharm Unserer Zeit. 2010 Mar;39(2):142-6. doi: 10.1002/pauz.201000362. Review. German. No abstract available.

PMID:
20196042
9.
11.

Anti-diabetic and anti-hypertensive potential of sprouted and solid-state bioprocessed soybean.

McCue P, Kwon YI, Shetty K.

Asia Pac J Clin Nutr. 2005;14(2):145-52.

12.

Current therapies and emerging targets for the treatment of diabetes.

Wagman AS, Nuss JM.

Curr Pharm Des. 2001 Apr;7(6):417-50. Review.

PMID:
11281851
13.
14.

Effect of a novel proteoglycan PTP1B inhibitor from Ganoderma lucidum on the amelioration of hyperglycaemia and dyslipidaemia in db/db mice.

Wang CD, Teng BS, He YM, Wu JS, Pan D, Pan LF, Zhang D, Fan ZH, Yang HJ, Zhou P.

Br J Nutr. 2012 Dec 14;108(11):2014-25. doi: 10.1017/S0007114512000153. Epub 2012 Mar 27.

PMID:
22453054
15.
16.

Glycogen phosphorylase inhibitors.

Henke BR, Sparks SM.

Mini Rev Med Chem. 2006 Aug;6(8):845-57. Review.

PMID:
16918491
17.
18.

Prospects for kinase activity modulators in the treatment of diabetes and diabetic complications.

Bullock WH, Magnuson SR, Choi S, Gunn DE, Rudolph J.

Curr Top Med Chem. 2002 Sep;2(9):915-38. Review.

PMID:
12171564
19.

Antihyperglycemic effect of the traditional Chinese scutellaria-coptis herb couple and its main components in streptozotocin-induced diabetic rats.

Liu SZ, Deng YX, Chen B, Zhang XJ, Shi QZ, Qiu XM.

J Ethnopharmacol. 2013 Jan 30;145(2):490-8. doi: 10.1016/j.jep.2012.11.017. Epub 2012 Nov 23.

PMID:
23183087
20.

[Advance in studies on anti-diabetic mechanism of Gardeniae Fructus and its active ingredient geniposide].

Yao DD, Shu L, Yang L, Jia XB.

Zhongguo Zhong Yao Za Zhi. 2014 Apr;39(8):1368-73. Review. Chinese.

PMID:
25039166

Supplemental Content

Support Center